GuruFocus Premium Membership

Serving Intelligent Investors since 2004. Only 96 cents a day.

Free Trial

Free 7-day Trial
All Articles and Columns »

Allos Therapeutics Inc. (ALTH) CEO Paul L Berns sells 32,580 Shares

February 10, 2010 | About:
insider

insider

57 followers
CEO of Allos Therapeutics Inc. (ALTH) Paul L Berns sells 32,580 shares of ALTH on 02/08/2010 at an average price of $7 a share.

Allos Therapeutics Inc. has a market cap of $721.4 million; its shares were traded at around $6.94 .

ALTH is in the portfolios of George Soros of Soros Fund Management LLC, Paul Tudor Jones of The Tudor Group, Bruce Kovner of Caxton Associates.

This is the annual revenues and earnings per share of ALTH over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of ALTH.


CEO Recent Trades:



  • Sell:: CEO Paul L Berns sold 65,160 shares of ALTH stock on 01/08/2010 at the average price of 7, the price of the stock has decreased by 0.86% since.



This is the insider trade history vs. stock price of ALTH. For the complete insider trading history of ALTH, click here.




Directors and Officers Recent Trades:



  • Buy:: VP, Pharmaceutical Operations Bruce K Jr Bennett bought 211 shares of ALTH stock on 12/31/2009 at the average price of 5.59, the price of the stock has increased by 24.15% since.
  • Sell:: Director Stephen J Hoffman sold 136,286 shares of ALTH stock on 01/11/2010 at the average price of 7.06, the price of the stock has decreased by 1.7% since.
  • Sell:: Director Stephen J Hoffman sold 116,285 shares of ALTH stock on 01/06/2010 at the average price of 6.67, the price of the stock has increased by 4.05% since.


About the author:

insider
GuruFocus - Stock Picks and Market Insight of Gurus

Rating: 3.0/5 (5 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK